Cargando…
Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases
Accumulating evidence over the past decade has linked the development of metabolic syndrome related to diabetes to variations in gut microbiota, an emerging, critical homeostatic regulator of host energy metabolism and immune responses. Mechanistic studies in rodent models have revealed an ever-incr...
Autores principales: | Li, Xuan, Watanabe, Keita, Kimura, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742320/ https://www.ncbi.nlm.nih.gov/pubmed/29326727 http://dx.doi.org/10.3389/fimmu.2017.01882 |
Ejemplares similares
-
Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
por: Pan, Quanren, et al.
Publicado: (2021) -
Microbial dysbiosis in the gut drives systemic autoimmune diseases
por: Mousa, Walaa K., et al.
Publicado: (2022) -
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
por: Teramoto, Yoshiki, et al.
Publicado: (2023) -
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
por: Roversi, Katiane, et al.
Publicado: (2021) -
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
por: Ancona, Giuseppe, et al.
Publicado: (2023)